| Title: | Cross-sectional metabolic subgroups and 10-year follow-up of cardiometabolic multimorbidity in the UK Biobank |
| Journal: | Scientific Reports |
| Published: | 21 May 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/35597771/ |
| DOI: | https://doi.org/10.1038/s41598-022-12198-1 |
| URL: | https://www.nature.com/articles/s41598-022-12198-1.pdf |
Publication 10245
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
We assigned 329,908 UK Biobank participants into six subgroups based on a self-organizing map of 51 biochemical measures (blinded for clinical outcomes). The subgroup with the most favorable metabolic traits was chosen as the reference. Hazard ratios (HR) for incident disease were modeled by Cox regression. Enrichment ratios (ER) of incident multi-morbidity versus randomly expected co-occurrence were evaluated by permutation tests; ER is like HR but captures co-occurrence rather than event frequency. The subgroup with high urinary excretion without kidney stress (HR = 1.24) and the subgroup with the highest apolipoprotein B and blood pressure (HR = 1.52) were associated with ischemic heart disease (IHD). The subgroup with kidney stress, high adiposity and inflammation was associated with IHD (HR = 2.11), cancer (HR = 1.29), dementia (HR = 1.70) and mortality (HR = 2.12). The subgroup with high liver enzymes and triglycerides was at risk of diabetes (HR = 15.6). Multimorbidity was enriched in metabolically favorable subgroups (3.4 ≤ ER ≤ 4.0) despite lower disease burden overall; the relative risk of co-occurring disease was higher in the absence of obvious metabolic dysfunction. These results provide synergistic insight into metabolic health and its associations with cardiovascular disease in a large population sample.</p>
4 Authors
- Anwar Mulugeta
- Elina Hyppönen
- Mika Ala-Korpela
- Ville-Petteri Mäkinen
1 Application
| Application ID | Title |
|---|---|
| 29890 | Synergistic genetic and environmental covariates of depression, diabetes and cognitive decline |
Enabling scientific discoveries that improve human health